Sleepy Hollow, NY, United States of America

Brian Zambrowicz

This inventor holds 22 USPTO granted patents and 20 published patent applications, plus 2 CIPO patents and 9 EPO patents, primarily in Genetic Engineering. Top assignees: Regeneron Pharmaceuticals, Inc., Regeneran Pharmaceuticals, Inc., Alnylam Pharmaceuticals, Inc.. Active years: 2021-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Brian Zambrowicz. Retrieved from https://idiyas.com/inventor/brian-zambrowicz-a3hr2xyf

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 22 

% Patents Active = 95.5

 

 

Average Co-Inventor Count = 5.7

ph-index = 2

Forward Citations = 17(Granted Patents)


Company Filing History:


Years Active: 2021-2026

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
CRISPR
Genetic Modification
Tauopathy
Humanized Locus
Antigen-Binding Proteins
Mouse Models
Nuclease-Mediated
Transcription Modulation
Embryonic Stem Cells
Gene Editing
Targeted Therapy
Mood Disorders
22 patents (USPTO):Explore Patents

Title: The Innovative Mind of Brian Zambrowicz: A Journey Through His Patents and Collaborations

Introduction: Brian Zambrowicz, a prominent inventor located in Sleepy Hollow, NY, has made significant contributions to the field of biotechnology. With a remarkable portfolio comprising 17 patents, Brian has dedicated his career to developing innovative methods and compositions that advance our understanding of human-albumin-targeting reagents and antigen-binding proteins.

Latest Patents: Among his latest achievements, Brian has patented methods for producing antigen-binding proteins against foreign antigens. These developments provide essential frameworks for generating proteins that can effectively target specific antigens of interest. Additionally, he has invented a versatile method utilizing genetically modified mice that express human albumin. This innovative approach provides models for assessing the efficacy of human-albumin-targeting reagents, including nuclease agents aimed at human albumin.

Career Highlights: Throughout his career, Brian has been associated with notable companies such as Regeneron Pharmaceuticals, Inc. His experience in these leading pharmaceutical firms has enabled him to hone his expertise and contribute significantly to biopharmaceutical research and development.

Collaborations: Brian has worked closely with esteemed colleagues, including David Frendewey and Marine Prissette. These collaborations have likely fostered a dynamic exchange of ideas and techniques, further enhancing the innovative outcomes of their combined efforts.

Conclusion: Brian Zambrowicz represents the spirit of innovation in the field of biotechnology. His 17 patents reflect his commitment to advancing medical science and his ability to collaborate effectively within teams. With continued dedication to his work, Brian is sure to shape future developments in biomedical research and applications.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…